Prosecution Insights
Prosecution Insights
7 pending office actions • 6 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 12 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (14%) |
| §103 only | 1 (14%) |
| §112 only | 1 (14%) |
| Multi-statute (no §101) | 4 (57%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| AYAD, TAMIR | 1 | 42.0% | +48.4% |
| MCINTOSH III, TRAVISS C | 1 | 73.2% | +14.0% |
| YU, TIAN NMN | 1 | 55.3% | +18.7% |
| WHITE, ASHLEY TAYLOR | 1 | 26.3% | +45.7% |
| NOTTINGHAM, KYLE GREGORY | 1 | 59.3% | +34.9% |
| PHAKOUSONH, DARAVANH | 1 | 33.3% | +100.0% |
| KAUFMAN, CLAIRE M | 1 | 63.3% | +51.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17280550 | METHODS AND PHARMACEUTICAL COMPOSITION COMPRISING TAFA4 FOR REDUCING SKIN INFLAMMATION | KAUFMAN, CLAIRE M | 45d overdue |
| 18013713 | PROCESS FOR PREPARING ALKYL POLYGLUCOSIDES, AND ALKYL POLYGLUCOSIDES OBTAINED ACCORDING TO THE PROCESS | WHITE, ASHLEY TAYLOR | 19d |
| 18564121 | RNA APTAMERS SPECIFIC FOR A-SYNUCLEIN PROTEIN FIBER CONFORMERS | YU, TIAN NMN | 82d |
| 19112100 | THERMOPLASMONIC DEVICE, RESPECTIVE WIRELESS ENERGY TRANSFER SYSTEM AND RESPECTIVE OPERATION METHOD | AYAD, TAMIR | — |
| 18714018 | INHIBITORS OF ABNORMAL PHOSPHORYLATION AND TAU PROTEIN AGGREGATION | MCINTOSH III, TRAVISS C | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17280550 | METHODS AND PHARMACEUTICAL COMPOSITION COMPRISING TAFA4 FOR REDUCING SKIN INFLAMMATION | KAUFMAN, CLAIRE M | 45d overdue |
| 18013713 | PROCESS FOR PREPARING ALKYL POLYGLUCOSIDES, AND ALKYL POLYGLUCOSIDES OBTAINED ACCORDING TO THE PROCESS | WHITE, ASHLEY TAYLOR | 19d |
| 18001420 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FGFR3-RELATED COGNITIVE DEFICIT | NOTTINGHAM, KYLE GREGORY | 28d |
| 18564121 | RNA APTAMERS SPECIFIC FOR A-SYNUCLEIN PROTEIN FIBER CONFORMERS | YU, TIAN NMN | 82d |
| 19112100 | THERMOPLASMONIC DEVICE, RESPECTIVE WIRELESS ENERGY TRANSFER SYSTEM AND RESPECTIVE OPERATION METHOD | AYAD, TAMIR | — |
| 18714018 | INHIBITORS OF ABNORMAL PHOSPHORYLATION AND TAU PROTEIN AGGREGATION | MCINTOSH III, TRAVISS C | — |
| 17632201 | HARDWARE ARCHITECTURE FOR SPIKING NEURAL NETWORKS AND METHOD OF OPERATING | PHAKOUSONH, DARAVANH | — |
| Art Unit | Apps |
|---|---|
| 1726 | 1 |
| 1681 | 1 |
| 1653 | 1 |
| 1621 | 1 |
| 2121 | 1 |
| 1674 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19112100 | THERMOPLASMONIC DEVICE, RESPECTIVE WIRELESS ENERGY TRANSFER SYSTEM AND RESPECTIVE OPERATION METHOD | AYAD, TAMIR | 1726 | §102§103 | Non-Final OA | — | Pending | Mar 14, 2025 |
| 18714018 | INHIBITORS OF ABNORMAL PHOSPHORYLATION AND TAU PROTEIN AGGREGATION | MCINTOSH III, TRAVISS C | — | §102§112 | Non-Final OA | — | Pending | May 28, 2024 |
| 18564121 | RNA APTAMERS SPECIFIC FOR A-SYNUCLEIN PROTEIN FIBER CONFORMERS | YU, TIAN NMN | 1681 | §101§112 | Non-Final OA | 82d | Pending | Nov 27, 2023 |
| 18013713 | PROCESS FOR PREPARING ALKYL POLYGLUCOSIDES, AND ALKYL POLYGLUCOSIDES OBTAINED ACCORDING TO THE PROCESS | WHITE, ASHLEY TAYLOR | 1653 | §102§112 | Final Rejection | 19d | Pending | Dec 29, 2022 |
| 18001420 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FGFR3-RELATED COGNITIVE DEFICIT | NOTTINGHAM, KYLE GREGORY | 1621 | §112 | Non-Final OA | 28d | Pending | Dec 09, 2022 |
| 17632201 | HARDWARE ARCHITECTURE FOR SPIKING NEURAL NETWORKS AND METHOD OF OPERATING | PHAKOUSONH, DARAVANH | 2121 | §103 | Non-Final OA | — | Pending | Feb 01, 2022 |
| 17280550 | METHODS AND PHARMACEUTICAL COMPOSITION COMPRISING TAFA4 FOR REDUCING SKIN INFLAMMATION | KAUFMAN, CLAIRE M | 1674 | §102§103 | Final Rejection | 45d overdue | Pending | Mar 26, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial